SR

Seema Ravi Belani

Active Director Director DIN 01888482
DIN 01888482 First appointment Jul 1994 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 1994
Shareholding value •••• Premium profile

About Seema Ravi Belani

Data last updated:

Seema Ravi Belani is a Director at Enoch Pharmaceuticals Private Limited (since 1994). The company operates in Chemicals. Enoch Pharmaceuticals Private Limited reported revenue of ₹1.7 Lakh (FY 2020).

DIN 01888482
Primary Designation Director
Industry Chemicals
First Appointment 21 Jul 1994
Oldest Company Age 32 yrs
Largest company Enoch Pharmaceuticals Private Limited · ₹1.7 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jul 19941994₹1.7 Lakh (FY 2020)Active

Board colleagues of Seema Ravi Belani

Directorship timeline

Open interactive timeline →
Enoch Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Seema Ravi Belani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seema Ravi Belani

Seema Ravi Belani currently holds 1 directorship: Enoch Pharmaceuticals Private Limited (Director, since 21 Jul 1994, revenue ₹1.7 Lakh (FY 2020)).

Seema Ravi Belani was first appointed on 21 Jul 1994 as Director at Enoch Pharmaceuticals Private Limited.

The current boards of Seema Ravi Belani's companies include Deepika Ravi Belani (Enoch Pharmaceuticals Private Limited), Ravi Chetan Belani (Enoch Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available